BREAKING NEWS: New drug approved by the FDA for Duchenne muscular dystrophy. Learn more about this new treatment option.

Medical Educational Resource

We're accelerating the delivery of treatments and cures.

Genetic Testing and Considerations in Clinical Care

Activity Snapshot

Activity Type: 
On-Demand Webinar
Release Date: 
Wednesday, April 1, 2020
Sponsor Information: 

This program is supported in part by an independent medical education grant from Biogen.

Faculty

Tanya Bardakjian, MS, CGC
Senior Genetic Counselor
Neurology, The Hospital of The University of Pennsylvania
Activity Overview: 

In this webinar, Tanya Bardakjian, a senior genetic counselor from The Hospital of The University of Pennsylvania, provides an overview of genetic testing for neuromuscular diseases. Specifically, the covered topics are: the types of methods and the types of variants they detect, how to incorporate newer protocols into the diagnostic workup, and how to effectively utilize the expertise of genetic counselors.